Evidence map›Paper›PMID 29487104›Full record

ArticleRNA (New York, N.Y.)2018

Prp8 positioning of U5 snRNA is linked to 5' splice site recognition.

Andrew J MacRae, Megan Mayerle, Eva Hrabeta-Robinson, Robert J Chalkley, Christine Guthrie, Alma L Burlingame, Melissa S Jurica

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Research Progress on the Relationship Between PRPF8 and Cancer.Current issues in molecular biology · 2025
    Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Prp8 impacts cryptic but not alternative splicing frequency.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Andrew J MacRaeDepartment of Molecular Cell and Developmental Biology, University of California, Santa Cruz, California 95064, USA.
Megan MayerleDepartment of Biochemistry and Biophysics, University of California, San Francisco, California 94143, USA.
Eva Hrabeta-RobinsonDepartment of Molecular Cell and Developmental Biology, University of California, Santa Cruz, California 95064, USA.
Robert J ChalkleyDepartment of Pharmaceutical Chemistry, University of California, San Francisco, California 94122, USA.
Christine GuthrieDepartment of Biochemistry and Biophysics, University of California, San Francisco, California 94143, USA.
Alma L BurlingameDepartment of Pharmaceutical Chemistry, University of California, San Francisco, California 94122, USA.
Melissa S JuricaDepartment of Molecular Cell and Developmental Biology, University of California, Santa Cruz, California 95064, USA.
University of California, San Francisco · USUniversity of California, Santa Cruz · US

Funding

YEAST THREONINE &SERINE KINASESP41RR001614 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ORTIZ DE MONTELLANO, PAUL R · 1985 to 2011
$24.1M
BIOSYNTHESIS OF RNASR01GM021119 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GUTHRIE, CHRISTINE · 1985 to 2015
$12.9M
Bio-Organic Biomedical Mass Spectromy ResourceP41GM103481 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BURLINGAME, ALMA L · 2012 to 2015
$6.4M
Training Program/Molecular/Cell/Developmental BiologyT32GM008646 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI STROME, SUSAN · 1999 to 2018
$3.7M
Interpreting the Structure of the SpliceosomeR01GM072649 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI JURICA, MELISSA S · 2006 to 2016
$2.7M
PURCHASE OF LTQ FT-ICR HYBRID MASS SPECTROMETER: (HEI) PROTEOMICSS10RR019934 · NCRR · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI BURLINGAME, ALMA L · 2004 to 2004
$1.0M
PURCHASE OF MICRO LC/NANO ESIQQTOF MASS SPECTROMETERS10RR015804 · NCRR · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI BURLINGAME, ALMA L · 2001 to 2001
$500k
NCRR NIH HHS P41 RR001614NCRR NIH HHS S10 RR015804NCRR NIH HHS S10 RR019934NIGMS NIH HHS P41 GM103481NIGMS NIH HHS R01 GM021119NIGMS NIH HHS R01 GM072649NIGMS NIH HHS T32 GM008646
6 · The paper itself

Abstract

Prp8 is an essential protein that regulates spliceosome assembly and conformation during pre-mRNA splicing. Recent cryo-EM structures of the spliceosome model Prp8 as a scaffold for the spliceosome's catalytic U snRNA components. Using a new amino acid probing strategy, we identified a dynamic region in human Prp8 that is positioned to stabilize the pre-mRNA in the spliceosome active site through interactions with U5 snRNA. Mutagenesis of the identified Prp8 residues in yeast indicates a role in 5' splice site recognition. Genetic interactions with spliceosome proteins Isy1, which buttresses the intron branch point, and Snu114, a regulatory GTPase that directly contacts Prp8, further corroborate a role for the same Prp8 residues in substrate positioning and activation. Together the data suggest that adjustments in interactions between Prp8 and U5 snRNA help establish proper positioning of the pre-mRNA into the active site to enhance 5' splice site fidelity.

Indexed as

RNA Splice SitesCatalytic DomainHumansRibonucleoprotein, U4-U6 Small NuclearRibonucleoprotein, U5 Small NuclearRNA-Binding ProteinsRNA PrecursorsRNA, Small NuclearSaccharomyces cerevisiaeSpliceosomesPRPF8 protein, humanRibonucleoprotein, U4-U6 Small NuclearRibonucleoprotein, U5 Small NuclearRNA-Binding ProteinsRNA PrecursorsRNA, Small NuclearRNA Splice SitesU5 small nuclear RNA5′ exonchemical probingpre-mRNA splicingPrp8spliceosomeU5 snRNA

Identifiers

PMID29487104
PMCPMC5959246
OpenAlexW2789630613

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.